Wang F - Search Results

1

Comparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer.

Wang F, Ning F, Liu C, Hao Y, Li L, Yu Z, Chen S, Li B. Wang F, et al. Cell Biochem Biophys. 2015 Mar;71(2):1261-5. doi: 10.1007/s12013-014-0286-9. Cell Biochem Biophys. 2015. PMID: 25319074 Clinical Trial.

2

STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.

Liu C, Li X, Hao Y, Wang F, Cheng Z, Geng H, Geng D. Liu C, et al. Among authors: wang f. Aging (Albany NY). 2020 May 12;12(9):8680-8701. doi: 10.18632/aging.103191. Epub 2020 May 12. Aging (Albany NY). 2020. PMID: 32396871 Free PMC article.

3

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4.

Ning FL, Wang F, Li ML, Yu ZS, Hao YZ, Chen SS. Ning FL, et al. Among authors: wang f. Diagn Pathol. 2014 Jul 10;9:143. doi: 10.1186/1746-1596-9-143. Diagn Pathol. 2014. PMID: 25012722 Free PMC article.

4

Overexpression of miR-939-3p predicts poor prognosis and promotes progression in lung cancer.

Han X, Du C, Chen Y, Zhong X, Wang F, Wang J, Liu C, Li M, Chen S, Li B. Han X, et al. Among authors: wang f, wang j. Cancer Biomark. 2019;25(4):325-332. doi: 10.3233/CBM-190271. Cancer Biomark. 2019. PMID: 31322549

5

A phase II study of preoperative chemotherapy with modified FOLFOX6 followed by surgery and postoperative chemoradiation in patients with localized gastric adenocarcinoma.

Chen SS, Yang XC, Chi F, Yu WZ, Wang ZB, Ning FL, Yu ZS, Hao YZ, Li ML, Wang F, Geng DZ, Liu LH, Dong XJ, Peng XZ, Ji CX. Chen SS, et al. Among authors: wang f, wang zb. Oncol Res. 2013;20(7):327-32. doi: 10.3727/096504013x13639794277725. Oncol Res. 2013. PMID: 23879173 Clinical Trial.

6

Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.

Geng HT, Cheng ZW, Cao RJ, Wang ZB, Xing SZ, Guo C, Wang F, Liu CM, Chen SS, Cheng YF. Geng HT, et al. Among authors: wang f, wang zb. Oncol Rep. 2018 Nov;40(5):2778-2787. doi: 10.3892/or.2018.6647. Epub 2018 Aug 17. Oncol Rep. 2018. PMID: 30132532

7

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC.

Hao Y, Liu J, Wang P, Wang F, Yu Z, Li M, Chen S, Ning F. Hao Y, et al. Among authors: wang f, wang p. Int J Genomics. 2014;2014:846142. doi: 10.1155/2014/846142. Epub 2014 Aug 5. Int J Genomics. 2014. PMID: 25161997 Free PMC article.

8

A randomized controlled trial of conventional fraction and late course accelerated hyperfraction three-dimensional conformal radiotherapy for esophageal cancer.

Wang JH, Lu XJ, Zhou J, Wang F. Wang JH, et al. Among authors: wang f. Cell Biochem Biophys. 2012 Jan;62(1):107-12. doi: 10.1007/s12013-011-9267-4. Cell Biochem Biophys. 2012. PMID: 21858589 Clinical Trial.

9

Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.

Zhang DS, Wang DS, Wang ZQ, Wang FH, Luo HY, Qiu MZ, Wang F, Li YH, Xu RH. Zhang DS, et al. Among authors: wang f, wang ds, wang fh, wang zq. Cancer Chemother Pharmacol. 2013 Apr;71(4):1065-72. doi: 10.1007/s00280-013-2102-4. Epub 2013 Mar 13. Cancer Chemother Pharmacol. 2013. PMID: 23483298 Clinical Trial.

10

Platinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis.

Chen WW, Wang F, Xu RH. Chen WW, et al. Among authors: wang f. PLoS One. 2013 Jul 11;8(7):e68974. doi: 10.1371/journal.pone.0068974. Print 2013. PLoS One. 2013. PMID: 23874831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,180 results

Search Page

Filters